Intervention study on the visceral fat reduction by intake of tea catechin and inulin

Mikami Tatsuya0 个研究点目标入组 114 人开始时间: 2023年5月16日最近更新: 2023年10月17日

试验速览

暂无简介。

•Those who are participants in the 2023 Iwaki Health Promotion Project Medical Checkup and meet the following inclusion criteria.
•-Inclusin criteria-
•1. Men and women who are 20 years old or over and under 75 years of age
•2. Those with BMI of 23 kg/m2 or more
•3. Those with visceral fat area of 80 cm2 or more

•1. Those who with hepatic, renal, heart disease, respiratory disorders, digestive disorders, endocrine disorders, metabolic disorders, neuropathy, consciousness disorders, diabetes, hyperlipidemia, hypertension, or other diseases and who are receiving medication treatment and are judged to be inappropriate by a doctor.
•2. Those who take diabetes medications such as alpha-glucosidase inhibitors or biguanides that may affect the gut microbiota.
•3. Pregnant women (those who plan to become pregnant)
•4. Those who work night shifts at least once a week
•5. Those who have a history of gastrointestinal resection (excluding appendectomy)
•6. Those who have positive HBs antigen markers
•7. Those who have positive HCV antibody markers
•8. Those who have food allergies
•9. Those who are allergic to metal (stainless steel) or have a pacemaker in their body
•10. Those who have a history of malignant tumors
•11. Those who have a history of mental illness
•12. Those who have changes more than 2 kg of weight within 3 months of the start of this study
•13. Those who regularly use pharmaceuticals, etc. that may affect the present study
•14. Those who donated 200 mL or more of blood within one month of the start of the study, or those who plan to do so during the research period.
•15. Those who cannot measure with a visceral fat measuring device
•16. Other persons who are judged inappropriate by the principal investigator or the co-investigator

发起方

Mikami Tatsuya